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It is not surprising, in view of the truly amazing therapeutic results 
that may follow the use of sulfanilamide and  related compounds in 
streptococcus and other infections, that considerable effort has been 
devoted to explaining the precise method by which this drug produces 
its results.  The quest is not alone for the purpose of perfecting the 
drugs employed and their administration, but because in addition such 
investigations offer a  new means of approach to the mechanism of 
action of chemotherapeutic drugs in general, concerning which we have 
had far too little information. 
A bewildering series of facts are now available that bear on the mode 
of action of sulfanilamide on microorganisms, both in the test tube 
and in the animal body.  The difficulty in interpreting these facts 
has been due to over-emphasis on the particular findings of individual 
investigators on the study of a  single factor.  Thus there are those 
who would explain sulfanilamide action as a  direct effect upon the 
microorganism itself,  whether acting in  vivo or in  vitro.  In  other 
words, there are those who would still consider the animal body as a 
test tube, much as Pasteur  explained immunity in the early days of 
the development of ordered knowledge in this field.  There are others, 
however,  who  from  the  beginning  have  taken  cognizance  of  the 
importance of the cells of the body in the therapeutic results obtained 
by sulfanilamide. 
The Direct Action of Sulfanilamide on Streptococcus 
The effect of sulfanilamide on bacteria cannot be considered from 
the viewpoint of the action of this substance alone, but in the light of 
* Aided by a grant from the Dr. Philip Hanson Hiss, Jr., Memorial Fund. 
607 608  ACTION OF SULFANILAMIDE  ON  STREPTOCOCCUS.  11 
all other environmental factors that enter into the experiment.  In 
other words, sulfanilamide action depends on the balance of  a series 
of factors that enter into the composition of the medium in which the 
two  interacting  substances,  sulfanilamide  and  streptococcus,  are 
tested.  We are for the moment primarily considering the substances 
that enter into the reaction under the artificial conditions as observed 
in the test tube, leaving for later consideration the additional factors 
that intervene in the animal body. 
Thus we find on analysis from our own experiments and from those 
of others, that the growth of streptococcus is influenced in the test tube 
TABLE  I 
Factors That Influence the Growth  of Streptococci 
Favoring 
Good nutrient broth 
(Infusion  broth  with  best  peptone  at 
right pH (7.5)) 
Glucose 
Peptone 
Horse serum 
Rabbit serum (Gay and Clark) 
Defibrinated rabbit blood (Gay and Clark) 
Defibrinated  infant  blood  (Lyons  and 
Mangiaracine) 
Defibrinated  horse  blood  (White  and 
Parker) 
Necrotic  tissue  (peptone  ?)  (Lockwood, 
1938 a) 
Inhibiting 
Poor nutrient broth 
(Meat extract broth; peptone free broth; 
pH under 6.5 or over 8) 
Glucose peptone water (Nitti a d.) 
Washing streptococci  (thus removing pep- 
tone) (Lockwood, 1938 b) 
Saline  suspension  of  streptococci  (Mellon 
a d.) 
40°C. (White and Parker) 
Human serum (Colebrook et al.) 
Deleucocyted  human  blood  (Colebrook 
et al., Finklestone-Sayliss et al. ) 
Whole  defibrinated  human  blood  (Cole- 
brook et al., Lockwood, 1938 b) 
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by two sets of factors: those that favor the growth of the microorgan- 
ism, and those that inhibit it.  It would be impossible to enumerate 
these growth factors in the precise order of their excellence in favoring 
or in inhibiting the growth of  streptococcus,  but they  are  listed  in 
Table I, more or less in order of their significance. 
When tested in any of the favoring media, as listed above, sulfanil- 
amide by general agreement produces bacteriostasis  only.  Further- 
more, the degree of bacteriostasis depends inversely on the sum total 
of adjuvant growth factors present; thus in a series of comparisons the 
ratio of growth in the presence of sulfanilamide broth, as compared 
with plain broth, was as 1-32,500 in 24  hours.  The ratio was only F.  P.  GAY, A.  R.  CLARK, .]'. A.  STREET,  D.  W.  MILES  609 
1-10.6 in sulfanilamide rabbit serum, as compared with serum alone, 
because serum is a better medium. 
Experiment 1.--Comparison  of Degree of Bacteriostatic Action of Sulfanilamide 
in Broth and Rabbit Serum.-- 
Medium 
Infusion broth 
c~  c¢ 
Rabbit serum 
~¢  cc 
Sulfanilamide 
1-5000 
Present 
Present 
Inoculation 
StreP~iCocCUS 
-4-22 
cl 
Colonies 
24 hrs. 
6,500,000 
200 
410,000,000 
38,000,000 
48 hrs. 
110,000,000 
10 
90,000,000 
6,000,000 
On adding Certain additional inhibiting factors, none of which alone 
suffices to destroy the streptococcus, in other words by a summation of 
injury,  sulfanilamide becomes bactericidal.  For  example,  sulfanil- 
amide kills: (1) in poor nutrient broth; (2) by a less nourishing pep- 
tone; (3) on removal of peptone by washing streptococci (Lockwood, 
1938 b); (4) in glucose peptone without meat extract (Nitti et at.);  (5) 
after diluting in saline (Mellon et al.); (6) at 40°C. (White and Parker); 
(7)  in human serum  (Colebrook et al.);  (8)  in whole human blood 
(Colebrook e~ al.). 
To illustrate one of the simplest examples of this summation of 
injury effect on streptococcus, we may give the growth history in an 
experiment with our  streptococcus H  in good and  relatively poor 
peptone media, with and without sulfanilamide. 
Experiment  2.--An  18  hour infusion broth  culture of  streptococcus  H  was 
inoculated into tubes of two batches of infusion broth of the same pH (7.5),  but 
of which one batch, containing bactopeptone instead of neopeptone, promoted 
fair but not vigorous growth.  To parallel tubes of each kind of broth, sulfanil- 
amide (1-5000) was added.  The tubes were plated on 2 successive days and the 
colonies of streptococcus ascertained: 
Infusion  broth 
Neopeptone 
cc 
Bactopeptone 
Sulfanilamide  Inoculation 
1-5000  Streph°c°ccus 
--  :t:14 
Present  " 
~c 
Present  " 
Colonies 
24 hrs.  48 hrs. 
350,000,000  80,000 
3800  9000 
10,600,000  80,000,000 
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Sulfanilamide thus produced bactefiostasis in the superior (neopep- 
tone) broth and complete destruction in 48 hours in the less adequate 
(bactopeptone) broth. 
If we look on sulfanilamide as only one, although perhaps the most 
marked of the factors that inhibit test tube growth of streptococci, 
we may question whether other combinations of unfavorable growth 
factors might not likewise change bacteriostasls to destruction.  For 
example, would washed streptococci or saline suspensions of strepto- 
cocci be killed when grown at 40°C., instead of being merely inhibited 
at this temperature as they are in the excellent media employed by 
White and Parker?  We know of no direct answer to such questions. 
As we pointed out a  year ago  (Gay and Clark),  streptococci in- 
hibited  in  growth by  dilutions  of  sulfanilamide exhibit  involution 
forms and occur in long chains.  These alterations have been con- 
firmed by Lockwood, 1938 b, and a "dumping" reaction of the length- 
ened chains added by Meyer, 1938.  Lyons and Mangiaracine confirm 
all these changes and also the alterations we noted in colonial form. 
None of these involution forms are pathognomonic of the action of 
sulfanilamide  and  might  equally  well  occur  in  any  unfavorable 
medium. 
Although capsules have long been recognized as characteristic of the 
virulence of streptococci (Border), and in some measure responsible 
for it,  the original explanation of Levaditi and Vaisman, 1935 a, of 
the mode of action of sulfanilamide as due to interference with capsule 
formation,  has  not  met  with  general acceptance  (Gay  and  Clark; 
Long and  Bliss;  Colebrook and Kenny).  We  continue to find,  as 
already  pointed  out,  capsules on  streptococci  grown,  although  in- 
hibited, in the bodies and fluids of sulfanilamide-treated rabbits and 
mice.  It  still  remains  a  possibility,  as  emphasized by Lyons and 
Mangiaracine, that there are capsules and capsules, which, although 
apparently identical morphologically, may differ in antigenic constitu- 
tion and resistence to phagocytosis. 
Far more significant, we believe, is the failure of sulfanilamide to be 
adsorbed or diminished by the presence of the streptococcus that it 
affects.  It is true that Finklestone-Sayliss, Paine and Patrick found 
that a relatively  great concentration of fat derived fromyoung strepto- 
cocci causes sulfanilamide in an aqueous dilution of 1-2000 to diminish F.  P.  GAY, A.  R.  CLARK, J.  A.  STREET,  D.  W.  MILES  611 
in the watery phase by nearly one-half in 2 hours.  This may show 
that sulfanilamide is relatively more soluble in fat than in water, but 
under the conditions specified does not, we believe, show that sulfanil- 
amide in its operation on streptococcus is adsorbed by the fat in the 
microorganism.  Biirgers,  1937,  states  that  incubation  of  strepto- 
coccus  with  prontosil  soluble  renders  the  organisms more  rapidly 
permeable by crystal violet, as shown by the rapidity of staining. 
It has  apparently been proved by Yorke et al.  and Pedlow and 
Reiner that arsenical compounds and acriflavine, both of which are 
highly destructive for trypanosomes both in test tube and body, are 
rapidly fixed on these cells whether they be alive or dead.  Strangely 
enough we have been unable to find any extensive proof that bacterici- 
dal substances like optochin,  gentian violet and acriflavine are actually 
fixed on the microorganisms they affect, and diminished thereby in the 
supernatant fluid.  One of us (Gay and Beckwith) began experiments 
of this sort some years ago, and they have now been extended in con- 
nection with the present investigation as a check on the mode of action 
of sulfanilamide. 
In brief we find:  10 cc. of gentian violet (1-10,000)  or the same 
volume of acriflavine (1-10,000) is reduced one-half in color index on 
addition of 1 cc. of a concentrated (× 100) culture of streptococcus, 
in from 1 to 3 hours.  Correspondingly, the bactericidal titer is also 
reduced one-half.  In  the  presence of  rabbit  serum  (50  per  cent) 
acriflavine is more active than in broth; it is impossible to measure the 
color reduction in the presence of serum but the bactericidal titer is 
reduced one-half, as in broth. 
Turning now to  contact  between  sulfanilamide and  streptococci 
(100 cc. of an 18 hour broth culture reduced by centrifugalization to 
1 cc.), we have never been able to show that the drug, 10 cc. (1-10,000 
to 1-100,000), was reduced in strength in from 2 to 5 hours at room 
temperature.  The Marshall  colorimetric test for sulfanilamide was 
employed.  Every variation in the conditions of this test that occurred 
to us was tried: growth of the streptococcus in  20  per cent serum 
broth with subsequent addition to sulfanilamide broth; growth of the 
streptococcus in broth with sulfanilamide for 18 hours, or in serum 
sulfanilamide broth for 10 hours. 
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have grown streptococci in broth or in sulfanilamide broth 1-10,000 
for 18 hours and found that the sulfanilamide broth-grown organisms, 
in aliquot numbers, adsorbed as much but no more gentian violet than 
the  plain  broth-grown  organisms.  Observationally  there  was  no 
difference in the rapidity or intensity of staining of the organisms in 
the  two  preparations.  Furthermore,  neither  sulfanilamide-grown 
organisms nor organisms in the presence of sulfanilamide were found 
to be more susceptible to the action of gentian violet and acriflavine 
than normal organisms. 
The E~ect of Sulfanilamide  on the  Virulence Factors  of Streptococcus 
Apart from growth inhibition and morphological changes wrought 
by sulfanilamide on the streptococcus, alteration and reduction in the 
virulence factors  of streptococcus metabolism have been repeatedly 
claimed.  Although the non-lethal effect of sulfanilamide on strepto- 
coccus may change temporarily the invasiveness of the organism it 
does not lead to any permanent impairment in its inherent virulence, 
as we pointed out and as has been confirmed by Lyons and Mangiara- 
cine.  After 2 or 3 days growth in sulfanilamide broth, our strepto- 
coccus  H  (adapted  to  rabbits),  when  inoculated  intrapleurally  in 
rabbits (~.L.D.  i  10 chains), or intraperitoneally in mice (~.L.D. 
1000 chains), was just as virulent as the same organism grown in plain 
broth.  In  such  experiments the  scantier  growth in  sulfanilamide 
broth was adjusted to equal the number of organisms in the more 
luxuriant plain broth culture by dilution of the latter. 
But the retention of potential Pathogenicity does not mean that 
one  or  more of  the  virulence factors  may  not  be  temporarily in- 
hibited  in  the  presence  of  sulfanilamide.  We  have  attempted  to 
harmonize, for our own satisfaction, the somewhat discordant views 
that have been offered by numerous investigators on certain of the 
virulence factors,  notably hemotoxin, leucocidin and fibrinolysin. 
Hemotoxin  Production.--It  has  been  suggested as  an  hypothesis 
that the production of hemotoxin (hemolysin) may be inhibited when 
streptococci are in the presence of sulfanilamide or related compounds 
(]]Urgers,  1938; Meyer, 1938),  and some experimental work has been 
presented by  Osgood, by  Huntington, and  by  King,  Henschel and 
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Levaditi and Vaisman,  1935 b;  Meyer,  1937;  and  Gross,  Cooper and 
Lewis,  1938 a,  believed  that  although  hemotoxin is  formed it  may 
be inactivated by the drug.  There is evidence against  this alterna- 
tive  hypothesis,  in  the  hands  of  Kemp;  Gross,  Cooper  and  Lewis, 
1938 b; Huntington; Osgood and Powell. 
The following is a brief and general description of the methods used 
and the results obtained in our investigation of the effects of sulfanil- 
amide  upon  hemotoxin  produced  by  Streptococcus  kaemolyticus  in 
vitro. 
Organisms  were grown either in broth and in broth plus sulfanilamide  (con- 
centrations varying from 1-1000  to  1-10,000),  or in rabbit  serum and rabbit 
serum plus sulfanilamide  (same  concentrations) for periods of 27 to 72 hours. 
This incubation period permitted the sulfanilamide  to exert its modifying effects 
upon the organisms,  and one of these effects  was,  invariably, a  bacteHostasis. 
Because of this bacteriostatic effect, a plate count of the number of organisms in 
the control and in the sulfanilamide  tubes was made, so that in the experiments 
equal numbers of organisms could be obtained by dilution of the control.  Plate 
counts in the nineteen experiments indicated that growth of a  large inoculum 
(e.g. 0.2 cc. of an 18 hour culture) of Streptococcus kaemolyticus H, was always 
reduced in sulfanilamide  media as compared with the control. 
Organisms, then, which have been subjected for periods of 27 to 72 
hours to  the  action  of  sulfanilamide  were  compared  for hemotoxin 
production with  their  controls by means of the  hemotoxin test  de- 
scribed below: 
Hemotoxin Test.--0.2 cc. (~ 1,000,000 streptococci), 0.1 cc. and 0.1 cc., of a 1-10 
dilution, of the sulfanilamide-treated cultures were placed in separate Wasser- 
mann tubes.  Amounts of untreated cultures diluted to correspond, in number of 
organisms,  to the treated cultures were placed in other Wassermann tubes.  To 
each tube 1 cc. of a 1 per cent suspension of washed rabbit red blood corpuscles 
was added, and the volume brought up to 2 cc. by addition of broth.  The tubes 
were incubated at 37°C. and hemolysis noted at intervals by removing the tubes 
from the bath, centrifugalizing  lightly to carry down the red cells, and comparing 
each tube in a comparator block with a series of standards.  After each reading 
the tubes were shaken to resuspend  the red cells, and immediately reincubated. 
The readings were continued until complete hemolysis was observed. 
The results obtained  are as follows:  In  every case of exposure of 
the organisms to the drug (whether in broth or in serum) the amount 
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treated organisms was less than that produced by the controls.  That 
this  difference  in  hemolysis  represents  simply  an  inhibition  in  the 
ability to produce hemotoxin, or a delay only in its rate of production, 
is evident from the fact that in 15 of the 19 experiments at least one 
or more  dilutions  of  culture  of  treated  streptococci  (6  to  7  hours) 
finally produced 100 per cent hemolysis of the red cells. 
It seemed possible that the results obtained to this point might be 
due to the fact that the control organisms were growing more rapidly 
during  the  course of the test than  those organisms  which had  been 
previously  exposed to  the drug.  To  eliminate  this possibility as a 
factor in the results, five experiments were performed in which  (by 
means of frequent plate counts during the course of the test) a growth 
curve for the two cultures was obtained.  The growth curves of the 
control  and  treated  cultures  were essentially  parallel.  In  other 
words, the hemotoxin test was begun with equal numbers of untreated 
or sulfanilamide-treated  organisms  and  as  the  test  proceeded,  both 
series grew out at the same rate.  A  given number of the untreated 
streptococci produced hemolysis more rapidly than an equal number 
of sulfanilamide-treated  streptococci. 
In view of these results, the conclusion was reached that the differ- 
ence  in  rate  and  amount  of  hemolysis between untreated  controls 
and those exposed to the drug for 27 to 72 hours represents a definite 
though temporary alteration in  the ability of the  treated  organisms 
to produce hemotoxin. 
Experiments were also carried out to determine whether there was 
a  decrease in the hemotoxin content of young streptococcus cultures 
in  the presence  of sulfanilamide. 
Broth cultures were used in which the organisms were exposed to the action 
of the drug (concentrations of 1-1000 to 1-10,000) for periods varying from 3 to 15 
hours.  In some cases the media were enriched by the addition  of 2.5 per cent 
rabbit serum, in order to facilitate the production of hemotoxin.  The cultures 
were centrifugalized and the supernatant  fluids placed in contact with rabbit red 
cells for 30 or 60 minutes.  Varying dilutions of superuatant fluids of both sulfanil- 
amide broth and plain broth cultures were used, so that allowance might be made 
for the difference  in the number of organisms in the two cultures. 
Out of a series of tests, there was no indication that the sulfanilamide 
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control supernatant fluids.  The results of these experiments indicate 
that  culturing streptococci  in  the  presence  of  1-1000  to  1-10,000 
sulfanilamide for periods of 3 to 15 hours fails to alter the amount of 
hemotoxin produced by such treated cultures, and that the presence 
of the drug during the production of the toxin does not serve to neu- 
tralize it. 
To determine whether sulfanilamide has any "neutralizing" action 
on  hemotoxin  already  formed  in  vitro  by  untreated  streptococci, 
the following experiments were carried out.  Both Berkefeld filtrates 
and centrifugalized supernatant fluid of a  6 hour broth culture were 
prepared.  To varying amounts (0.4  cc.  to 0.9 cc.) of each, sulfanil- 
amide in concentrations from 1-100  to  1-2000  was added.  Appro- 
priate controls without sulfanilamide were prepared.  After one-half 
hour 1 cc. of a  1 per cent rabbit blood cell suspension was added and 
the time necessary for complete hemolysis noted.  The results indi- 
cated  that  sulfanilamide in  concentrations varying from  1-1000  to 
1-20,000 does not inhibit the hemolysis of  a  1 per cent red  cell  sus- 
pension.  In other words, the drug does not neutralize or inactivate 
preformed  hemotoxin present  in  the  filtrate or  supernatant  of  an 
untreated streptococcus culture. 
Another type of experiment was conducted in an effort to check the results of 
early experiments  of Osgood, who reported evidence  of neutralization of hemotoxin 
by sulfanilamide  as shown in blood agar plates.  1 cc. of a 1-5,000,000 dilution 
of an 18 hour streptococcus culture was added to blood agar containing sulfanil- 
amide in concentrations varying from 1-5000 to 1-100,000, and pour plates made. 
Corresponding plates  without  drug  were prepared.  One  series of plates  was 
incubated aerobically and another  anaerobically.  The  number of colonies on 
each plate was counted and the average diameter of the zone of hemolysis was 
determined by measuring 30  unselected colonies on  each plate.  The  colony 
count showed that the sulfanilamide was not bacteriostatic under these experi- 
mental conditions.  Measurements of the hemolytic zones indicated no decrease 
in the amount of hemolysis  present in the sulfanilamide  plates in either the aerobic 
or anaerobic series for any concentration of sulfanilamide used.  From  these 
results it was concluded that sulfanilamide in blood agar pour plates, incubated 
aerobically or anaerobically, does not neutralize the hemotoxin formed, or check 
the growth of streptococcus colonies  previously unexposed to the drug. 
The final conclusions from our experiments, then, would be  that 
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although  only  temporarily,  their  ability  to  produce  hemotoxin. 
However, when the unaffected streptococcus is grown in the presence 
of  varying amounts of  sulfanilamide for  short  periods  of  time,  no 
diminution in the hemotoxin formed can be noted.  No evidence was 
found that sulfanilamide neutralizes hemotoxin already formed.  In 
short, the supposed action of sulfanilamide on streptococcus hemo- 
toxin  can scarcely be used as explanatory of its therapeutic effect. 
Leucocidin  Production.--It  has  been  suggested  as  an  hypothesis 
without experimental proof that the therapeutic effect of sulfanilamide 
might be due to suppression of leucocidin formation, which property 
of streptococcus metabolism is known to be a factor in the virulence 
of this microorganism.  The mere inhibition of growth might produce 
this  result  quantitatively  (Mellon  and  Bambas;  Bliss  and  Long). 
As corroborative evidence, leucocytes are relatively more normal in 
presence of  sulfanilamide in  vitro  (Levaditi  and  Vaisman, 1935 b) 
or in marrow culture~ (Osgood) than when the drug is absent. 
We  have  attacked  this  problem  more  directly  in  the  following 
manner: 
Streptococcus was grown in plain broth, as control, or in broth plus sulfanila- 
mide (from 1-1000 to 1-10#00).  In ten different experiments, Berkefeld filtrates 
from such  cultures  or the  supernatant  fluids  (at  times heated  to  56°C.)  from 
centrifugalized cultures were used in varying amounts in order to equalize the 
difference  in number of organisms in  the  two media.  The Neisser-Wechsberg 
technique was employed (Gay and Oram). 
In no  instance was  any difference in  the  leucocidin content,  as 
measured by reduction of methylene blue, detected in the fluids of 
the sulfanilamide-grown cultures as  compared with those  of  broth 
controls.  Moreover,  when  direct  observations  were made  on  the 
appearance of  the  cells, in from 30  minutes to  2  hours,  we  could 
detect no difference in the degree of their injury in the two kinds of 
fltrates. 
Fibrinolysin Production.--The  species specific fibrinolysin formed 
by the hemolytic streptococcus is assuming an increasingly important 
significance in pathogenesis.  Neither Huntington  nor  Kemp were 
able to demonstrate the inhibition of fibrinolysin in the presence of 
sulfanilamide  experimentally. F.  P.  GAY,  A.  R.  CLARK,  J'.  A.  STREET,  D.  W.  MILES  617 
In order to  determine whether sulfanilamide interferes with  the 
production or the activity of fibrinolysin, streptococcus was grown 
in broth plus sulfanilamide (1-10,000)  or in broth without sulfanil- 
amide for 24, 48 or 72 hours.  At these intervals the cultures were 
plated to determine the relative number of living organisms.  The 
Berkefeld filtrates from these cultures, used in varying amounts to 
equalize  the  differences in  number  of  organisms,  were  tested  for 
fibrinolytic activity, by the technique of Tillett and Garner.  In all 
cases  the filtrates  of sulfanilamide broth  cultures lysed the human 
clots at the same rate as did the filtrates from the plain broth cultures. 
The fibrinolytic activity of the broth suspensions of the centrifugal- 
ized organisms from the 48  hour sulfanilamide broth  cultures was 
also compared with that of the suspensions of the broth-grown organ- 
isms, diluted in order to compare equivalent number of organisms. 
The degree of lysis was noted at intervals and as soon as lysis of a clot 
was complete the number of organisms was determined by plating 
the  contents of  the  tube. 
The intervals of time for complete lysis of the clots by the organisms 
from sulfanilamide broth cultures were always longer than required 
for the lysis by the organisms from the broth cultures.  These results, 
then, would appear  to  indicate that  fibrinolysin is produced more 
slowly by the sulfanilamide-grown organisms, but the difference may 
be easily accounted for by the smaller number of sulfanilamide organ- 
isms  at  the  time of complete lysis.  The number of sulfanilamide 
broth-grown organisms was only one-third to one-tenth the number 
of  broth-grown  organisms  when  lysis  was  complete.  When  the 
fibrinolytic test was carried out with the control broth-grown organ- 
isms suspended in broth plus sulfanilamide (1-10,000)  they produced 
lysis as rapidly as those resuspended in plain broth and the number 
of living organisms at that time was approximately the same in the 
corresponding tubes. 
Thus, there is no inhibition in fibrinolysin production which is not 
directly referable to a difference in number of viable organisms. 
The Indirect Effect of Sulfanilamide on Streptococcus 
Sulfanilamide and related compounds that produce bacteriostasis 
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Stokinger,  to  increase the  normal oxidation-reduction potential  in 
the growth curve of the microorganism when grown aerobically.  It 
produces  similar  though  less  effect in  broth  alone.  Other  similar 
but  non-bacteriostatic  compounds  (e.g.,  prontosil)  have  no  such 
action.  It would seem that this change is in some way related to the 
effect of the drug on the streptococcus. 
The suggestion of Main, Shinn and MeLlon, and Locke, Main and 
Mellon that sulfanilamide may act as an anticatalase, thereby allow- 
ing unhampered production of peroxide, with harmful effect on the 
streptococcus, may also be a  factor of importance.  This  does not 
account, however, for the fact that repeated doses of sulfanilamide 
fail to convert bacteriostasis to a true lethal effect. 
Turning to another aspect of the indirect action of sulfanilamide, 
there is,  and has been since the beginning of studies on this drug, 
evidence of its action simply as an adjuvant to the natural defense 
mechanism  of  the  body.  From  the  earliest  studies  the  probable 
significance of mobile cell intervention has been mentioned (Domagk, 
1935; Levaditi and Vaisman, 1935 c; Long and Bliss; Btirgers, 1937), 
and in later publications this was verified by more direct observations 
of macrophage phagocytosis by Levaditi and by Domagk, 1937. 
The reticulo-endothelial system would not seem directly concerned 
with  the  rapid  results  obtained in  chemotherapy by  sulfanilamide 
(Levaditi and Vaisman, 1935 c; Gross, Cooper and Peebles).  In our 
previous publication we also found no histological change in the fixed 
tissues which would account for the macrophage accumulation that, 
in  our minds,  accounts for  the  second and  ultimately destructive 
effect in vivo that follows bacteriostasis by the drug.  Although pro- 
longed use of the drug does apparently lead to a reticulo-endothelial 
proliferation, in the hands of Davis et aL,  this cannot, we believe, 
account for the immediate chemotherapeutic result.  Sulfanilamide 
does not in itself attract leucocytes (Gay and Clark; Coman).  There 
is no evidence that the microorganisms become drug-fast  (Osgood). 
What the drug does do to the organisms is to render them temporarily 
impotent, and to reduce in slight degree their pathogenic properties. 
This inhibitory effect allows mobile cells,  particularly  the  mononu- 
clear cells of the connective tissue,  the opportunity to accumulate, 
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lation  we  have  already  demonstrated  histologically  in  the  pleural 
walls. 
Our  hypothesis  as  to  the  signal  importance  of  host  cells in  sul- 
fanilamide  cure  has hitherto  been based largely on these histological 
studies  of the  tissues surrounding  an  area in  which  cure  under  the 
influence of sulfanilamide  was taking  place.  The  work as reported 
seemed to show a  direct  relationship  between the  disappearance  of 
the enfeebled  streptococcus and local mononuclear cell mobilization. 
We turn now to evidence tending to show that phagocytosis is more 
active with sulfanilamide-treated cocci or in the body of sulfanilamide- 
treated  animals.  For this  approach we find more corroboration  by 
other writers.  Finkelstein and Birkeland found that guinea pig blood 
leucocytes phagocyted in vitro more streptococci in  the presence of 
sulfanilamide  in  certain  concentrations.  Biirgers,  1938;  Osgood; 
and  Mellon  and  Bambas,  however, found no  evidence of any  such 
alleged opsonic action.  We have used leucocytes both from rabbit 
and guinea pig exudates and completely failed to confirm the results 
of  Finkelstein  and  Birkeland. 
We have approached this question experimentally in three different 
ways: 
1. Sterile exudates were obtained from the pleural cavities of rabbits  which 
had been inoculated with an aleuronat-starch  mixture 24 or 48 hours previously. 
Some of the rabbits had received subcutaneously 4 to 7 injections of 10 or 20 cc. 
each of sulfanilamide (2 per cent).  The  injections were given from 24 or 48 
hours until 3 to 4 hours before removal of the exudate.  The controls were un- 
treated.  Streptococcus H  (0.1 cc. or 0.2  cc. of an 18 hour broth culture)  was 
added to the two kinds of pleural exudates (0.3 cc.  to 0.8 cc.) and kept at 37°C., 
with constant agitation.  Films were made at 1 and 2 hour intervals.  At least 
200 cells from each preparation were counted.  In six experiments the amount of 
phagocytosis was practically the same in the exudates of the treated  (average of 
phagocytic cells 4 per cent), as of the normal rabbits  (average of phagocytic cells 
3.5 per cent). 
2. When immune serum was added  to the  exudates there was slightly more 
phagocytosis in the exudate of the  sulfanilamide-treated rabbits (average phago- 
cytic cells 8.5 per cent)  than  in  the normal  exudate  (average phagocytic ceils 
6.5 per cent). 
These experiments show clearly that no definite difference is observ- 
able in the in vitro phagocytosis by exudate cells from sulfanilamide- 620  ACTION  O]~  SUL]~ANILAMIDE  ON  STREPTOCOCCUS.  II 
treated  rabbits,  as  compared  with  that  of  normal  rabbits.  The 
experiments, however, do not reproduce the actual conditions that 
obtain in therapeutic results in the body, in which latter the strepto- 
cocci have been subjected over a longer period of time to successive 
doses of sulfanilamide. 
Lyons and  Mangiaracine have found that adult or infant human 
leucocytes, which have no effect on normal streptococci, do phagocyte 
streptococci that have been repeatedly subcultured in sulfanilamide. 
Our experiments with rabbit leucocytes agree with these results: 
3. Leucocytes were obtained from the pleural exudate of 24, 48 and 72 hour 
aleuronat-starch prepared rabbits in  six  different  experiments.  Cultures  were 
grown 24, 48 and 72 hours, either in plain broth or in broth containing sulfanilam- 
ide 1-10,000.  Mixtures of whole exudate or its leucocytes in serum were made 
with  treated  and  untreated  streptococci. 
counts made after ½ and 1 hour.  Smears. 
were counted. 
Whole exudate 
Sulfanilamide broth streptococci 
Broth streptococci 
Leucocytes +  normal rabbit serum, 56°C. 
Sulfanilamide broth streptococci 
Broth streptococci 
Leucocytes +  rabbit immune serum 
Sulfanilamide broth streptococci 
Broth streptococci 
Tubes  were  agitated at  37°C.  and 
200 cells or more of each preparation 
Average of phagocytic cells 
#er cent 
31.3 
21 
28.5 
9 
42.5 
34.1 
In all instances phagocytosis is greater when sulfanilamide-grown 
streptococci are put in contact with pleural exudate leucocytes, from 
the rabbit.  This is true whether the phagocytic index is based on the 
percentage of all ceils that are phagocytic or on the average number 
of chains of streptococci in each phagocytic cell. 
When we turn to observations on the degree of phagocytosis in the 
animal  body  under  treatment  with  sulfanilamide,  several  sets  of 
experiments are  already  available.  Levaditi and Valsman,  1935 c, 
Bliss and Long, and Domagk, 1937, have all given evidence that the 
peritoneal  exudate  of  sulfanilamide-treated  mice  shows  greater 
phagocytosis of streptococci than the exudate of normal animals. ~.  1  ~.  GAY,  A.  R.  CLARK,  J. A.  STREET,  D.  W.  MILES  62t 
Our own  experiments  along this line, both  in mice and in  rabbits, 
also seem unequivocal. 
1. Injection  of  Sulfanilamide-Grown  or Normal  Streptococci Intraperitoneally 
in Mice.--Streptococci  grown  for  48  hours,  either in  plain  broth  or  1-10,000 
sulfanilamide broth,  were  centrifugalized and,  after  conservation  at  0 °  while 
counts were made, were suspended in fresh broth so as to give the same number of 
organisms per cc.  0.5 or 1 co. amounts of such suspensions were injected intra- 
peritoneaily in mice.  The cavities had usually been prepared 2 to 3 hours before 
by broth injection.  The exudates were examined in smears from  ½  to 6  hours 
later.  Mter 4 hours the organisms were so numerous that accurate counts  were 
impossible.  Both types of culture produce a fatal infection. 
In the earlier stages  (~  to  1 hour)  the average number  of phagocytic  cells 
containing sulfanilamide streptococci was 33.3  per cent,  whereas  only 20.3  per 
cent of cells contained the normal broth organisms.  Counts made at later intervals 
showed much less difference, indirectly indicating that the  sulfanilamide-treated 
organisms had regained their virulence. 
2.  Phagocytosis of Streptococci in Peritoneal Cavities of Mice Treated with Sulfan- 
ilamide, and of Normal Mice.--Mice were given intraperitoneal injections of 1 co. 
(1-100)  to 0.5 co.  (1-10) of an  18 hour broth culture of streptococcus  H.  This 
is approximately 1000 ~r.l~.D. as this culture, adapted to rabbits, is relatively less 
virulent for mice.  Cavities of a few were prepared 2 to 3 hours previously with 
broth.  Half of the mice were treated subcutaneously with 0.5 co. of 2 per cent 
sulfanilamide and the others left as controls.  The majority of the treated animals 
were given the drug 2 and 4 hours after infection, but a  few received it simulta- 
neously or a  few hours previously.  Observations and counts were made on the 
exudates removed at hourly intervals for from 2  to 8  hours.  Observations on 
7 treated animals and 6 controls are included.  5 controls were dead before 24 
hours, and 1 treated mouse died in 48 hours. 
The average counts of phagocytic ceils on the entire range from 2 to 8 hours 
do not show any higher percentage of phagocytosis in the sulfanilamide-treated 
mice than in the controls.  When  the counts  of the later periods only (6 to 8 
hours) were averaged, there was a  slight difference shown,  10.8 per cent for the 
sulfanilamide-treated  mice, and 7 per cent for the control mice. 
3.  Pkagocytosis in Pleural Cavities of Rabbits  Treated with Sulfanilamide  as 
Compared with That in Cavities of Normal Rabbits.--Rabbit pleural cavities were 
prepared either 24 or 48 hours previously with aleuronat-starch, or 3 hours pre- 
viously with  broth,  and  injected intrapleurally with  concentrated fresh broth- 
grown cultures  of streptococcus  H  (approximately 250 million).  Half of  these 
rabbits (total 4) were given injections of sulfanilamide subcutaneously; the first 
1 to 3 hours before and a  second simultaneously, or 1 hour after the injection of 
streptococcus.  The exudates were examined 2 to 4 hours after infection.  There 
was a control rabbit in each of the four experiments tried. 622  ACTION OF SULFANILAMIDE  ON  STREPTOCOCCUS.  II 
The average percentage of phagocytic cells in the sulfanilamide-treated rabbits 
was 14 per cent, as contrasted with 5 per cent phagocytic cells in the control 
rabbits. 
It is difficult in experiments of this type, and particularly with the 
strain we have employed, to obtain conditions of treatment by sul- 
fanilamide that will result in cure, and at the same time guarantee the 
presence of sufficient numbers of streptococci to afford good estimates 
of the degree of phagocytosis.  In our mouse experiments, sulfanil- 
amide-grown streptococci are at first better phagocyted in vivo than 
are  normal  cocci.  In  the  experiments  with  sulfanilamide-treated 
mice, although a  curative dose is used, superior phagocytosis is not 
dearly  demonstrable. 
Our experiments in the rabbit pleural cavity would seem clearly to 
indicate that even when enormous multiples of the lethal dose  are 
employed  (to  give  phagocytic  pictures)  phagocytosis  is  definitely 
superior in sulfanilamide-treated animals, as contrasted with untreated 
rabbits. 
CONCLUSIONS 
The precise mode of therapeutic action of sulfanilamide on strepto- 
coccus can be arrived at only by considering the sum total of factors 
that inhibit or favor the natural growth of the microorganism under 
the experimental conditions that obtain, whether in vivo or in vitro. 
Too sweeping conclusions have Mtherto been drawn from the study of 
a  single variable factor, such as an unfavorable temperature or the 
absence or presence of peptone.  We have attempted here to analyze 
the factors that have hitherto been recognized and some new ones, 
but particularly the relationship of these factors to one another. 
The result obtained on adding sulfanilamide to the streptococcus 
in the test tube is usually bacteriostasis and not complete destruction 
of even small numbers of bacteria.  This is on the condition that the 
suspending medium is a  favorable one for the growth of the micro- 
organism;  the  more growth-promoting the  medium is  the  less  the 
bacteriostasis.  If,  on  the other hand,  the  medium is  too  poor,  or 
one that in itself inhibits growth, the addition of sulfanilamide may 
lead to sterilization of the culture. F.  P.  GAY, A.  R.  CLARK, ~'.  A.  STREET, D.  W.  MILES  623 
The cofiditions for growth of the streptococcus in the body of the 
rabbit or mouse, depend on the strain of bacteria used, but are on the 
whole favorable.  Defence, however, in the form of phagocytosis by 
both polymorphonuclear and by mononuclear cells is attempted even 
in the susceptible animal.  When sulfanilamide is used to treat such 
an animal, or when sulfanilamide-grown (inhibited) streptococci are 
employed, phagocytosis is pronounced, whether studied in the test 
tube or in the animal body.  In the rabbit the delay by sulfanilamide 
and  resultant  increased phagocytosis by polymorphonuclears allows 
mononuclear cells to accumulate and recovery may result. 
Sulfanilamide not only does not  completely destroy the  strepto- 
coccus but does not even impair its innate virulence.  It acts upon 
the streptococcus not only by inhibiting growth but by a temporary 
inhibition of hemotoxin formation, but only under certain conditions. 
The drug does not neutralize hemotoxin already formed.  No  sig- 
nificant  effect  of  sulfanilamide on  the  formation  of  leucocidin  or 
fibrinolysin by streptococcus has been evident in our experiments. 
Sulfanilamide differs in one important  respect from other drugs 
that are destructive either in the test tube or actually in the body, for 
protozoa and bacteria.  Protozoa fix or adsorb arsenicals and acri- 
flavine that kill them variably in vitro  and in vivo.  Streptococci fix 
both gentian violet and acriflavine, which dyes have marked destruc- 
tive action in the test tube but are less effective in vivo.  Sulfanilamide 
is not diminished at all by contact in vitro with large masses of strepto- 
cocci, nor does the action of this drug render the microorganism more 
capable than untreated cocci to adsorb gentian violet or acriflavine, 
or to be destroyed by these highly bactericidal substances. 
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